[公告]7批次人用狂犬疫苗查出质量问题 流向已经查清
<p class="MsoNormal" style="TEXT-INDENT: 24.1pt; LINE-HEIGHT: 25pt; mso-char-indent-count: 2.0; mso-line-height-rule: exactly"><b style="mso-bidi-font-weight: normal"><span style="FONT-SIZE: 12pt; mso-bidi-font-size: 10.5pt"><span lang="EN-US"><?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></span></span></b> </p>
<p class="MsoNormal" style="TEXT-INDENT: 21pt; LINE-HEIGHT: 25pt; mso-char-indent-count: 2.0; mso-line-height-rule: exactly"><span lang="EN-US"><o:p> </o:p></span></p>
<p class="MsoNormal" style="TEXT-INDENT: 21pt; LINE-HEIGHT: 25pt; mso-char-indent-count: 2.0; mso-line-height-rule: exactly">大家都新闻了吗？近日来，国家食品药品监督管理局在对“人用狂犬病疫苗”监督检查中发现，“江苏延申生物科技股份有限公司”和“河北福尔生物制药股份有限公司”<span lang="EN-US">7</span>个批次“人用狂犬病疫苗”质量存在问题。问题疫苗几乎流向全国多个省区市，卫生部昨天晚上表示，各省市要做好问题疫苗受种者的咨询、登记，并按照“知情、自愿、免费”的原则，采用合格疫苗予以重新全程接种。看了下面的报告，你可能真的要仔细的想想，接种疫苗是防病还是害命？<span lang="EN-US"><o:p></o:p></span></p>
<p class="MsoNormal" style="TEXT-INDENT: 21pt; LINE-HEIGHT: 25pt; mso-char-indent-count: 2.0; mso-line-height-rule: exactly"><span style="mso-ascii-font-family: Arial">报告一：</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥; mso-ascii-font-family: Arial">“</span><span style="mso-ascii-font-family: Arial">江苏延申生物科技股份有限公司、河北福尔生物制药有限公司两家企业生产的</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥">7</span><span style="mso-ascii-font-family: Arial">批次</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥">215833</span><span style="mso-ascii-font-family: Arial">人份的</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥"><a href="http://news.sina.com.cn/c/2009-12-05/085519196114.shtml"><span lang="EN-US" style="COLOR: black; FONT-FAMILY: 宋体; TEXT-DECORATION: none; mso-hansi-font-family: ˎ̥; text-underline: none; mso-ascii-font-family: Arial"><span lang="EN-US">狂犬病疫苗存在质量问题</span></span></a></span><span style="mso-ascii-font-family: Arial">：其有效成分低于国家标准，保护率可能因此降低，接种者有可能因得不到有效保护而患上狂犬病。</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥; mso-ascii-font-family: Arial">”</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥"> </span><span style="mso-ascii-font-family: Arial">这是</span><?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" /><st1:chsdate w:st="on" year="2009" month="12" day="8" islunardate="False" isrocdate="False"><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥">2009</span><span style="mso-ascii-font-family: Arial">年</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥">12</span><span style="mso-ascii-font-family: Arial">月</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥">8</span><span style="mso-ascii-font-family: Arial">日</span></st1:chsdate><span style="mso-ascii-font-family: Arial">，国家食品药品监管局新闻发言人颜江瑛在新闻发布会上就公众高度关注的问题狂犬病疫苗如实说。————相关</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥"><a href="http://video.sina.com.cn/news/c/v/2009-12-09/080149509.shtml"><span lang="EN-US" style="COLOR: black; FONT-FAMILY: 宋体; TEXT-DECORATION: none; mso-hansi-font-family: ˎ̥; text-underline: none; mso-ascii-font-family: Arial"><span lang="EN-US">视频</span></span><span lang="EN-US" style="COLOR: black; FONT-FAMILY: 宋体; TEXT-DECORATION: none; mso-hansi-font-family: ˎ̥; text-underline: none; mso-ascii-font-family: Arial"><span lang="EN-US">链接</span></span><span lang="EN-US" style="COLOR: black; FONT-FAMILY: 宋体; TEXT-DECORATION: none; mso-hansi-font-family: ˎ̥; text-underline: none; mso-ascii-font-family: Arial"><span lang="EN-US">：药监局称</span></span><span style="COLOR: black; TEXT-DECORATION: none; text-underline: none">21</span><span lang="EN-US" style="COLOR: black; FONT-FAMILY: 宋体; TEXT-DECORATION: none; mso-hansi-font-family: ˎ̥; text-underline: none; mso-ascii-font-family: Arial"><span lang="EN-US">万问题狂犬病疫苗存质量问题</span></span></a></span><span style="mso-ascii-font-family: Arial">（来源：东方卫视《看东方》）</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥"><o:p></o:p></span></p>
<p class="MsoNormal" style="TEXT-INDENT: 21pt; LINE-HEIGHT: 25pt; mso-char-indent-count: 2.0; mso-line-height-rule: exactly"><span style="mso-ascii-font-family: Arial">报告二：江苏延申生物科技股份有限公司、河北福尔生物制药有限公司两家企业生产的</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥">7</span><span style="mso-ascii-font-family: Arial">批次</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥">215833</span><span style="mso-ascii-font-family: Arial">人份人用狂犬病疫苗，在中检所抽样检查发现严重质量问题，在发现问题的同时，因疫苗有效期短，在采取召回措施时，问题疫苗已经流向</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥">27</span><span style="mso-ascii-font-family: Arial">个省区市的</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥">364</span><span style="mso-ascii-font-family: Arial">个疾控中心，并已于</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥">7</span><span style="mso-ascii-font-family: Arial">月份销售使用完毕。</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥"><o:p></o:p></span></p>
<p class="MsoNormal" style="TEXT-INDENT: 21pt; LINE-HEIGHT: 25pt; mso-char-indent-count: 2.0; mso-line-height-rule: exactly"><span style="mso-ascii-font-family: Arial">以下是问题疫苗已流向的</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥">27</span><span style="mso-ascii-font-family: Arial">个地区：</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥"><o:p></o:p></span></p>
<p class="MsoNormal" style="LINE-HEIGHT: 25pt; mso-line-height-rule: exactly"><span style="mso-ascii-font-family: Arial">安徽、福建、甘肃、广东、广西、贵州、海南、河北、河南、湖北、湖南、吉林、江苏、江西、内蒙古、山东、山西、四川、新疆、云南、重庆（江苏延申生物科技股份有限公司）</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥"><o:p></o:p></span></p>
<p class="MsoNormal" style="LINE-HEIGHT: 25pt; mso-line-height-rule: exactly"><span style="mso-ascii-font-family: Arial">北京、安徽、福建、甘肃、广西、贵州、海南、河北、河南、湖北、辽宁、内蒙古、青海、山东、山西、四川、西藏、浙江、重庆、宁夏（河北福尔生物制药有限公司）</span><span lang="EN-US" style="FONT-FAMILY: Arial; mso-hansi-font-family: ˎ̥"><o:p></o:p></span></p>
<p class="MsoNormal" style="TEXT-INDENT: 21pt; LINE-HEIGHT: 25pt; mso-char-indent-count: 2.0; mso-line-height-rule: exactly">报告三：据知情者透露，卫生部专家进行了风险评估，综合考虑犬病特征、问题疫苗流向、疫苗受众者暴露于带毒犬只情况及疫苗受众者接种日期距目前事件等因素，在接种问题疫苗的受众者中，有<span lang="EN-US">1134</span>人处于风险之中。也就是说在<span lang="EN-US">2008</span>年下半年至<span lang="EN-US">2009</span>年<span lang="EN-US">10</span>月期间注射过人用狂犬病疫苗的<span lang="EN-US">215833</span>位接种者有<span lang="EN-US">1134</span>人注射了质量存在问题的疫苗，最严重后果既是接种者因注射质量问题疫苗而没有起到疫苗效果，生命将直接受到狂犬病毒威胁！还不算病毒疫苗可能直接对人体造成的潜在威胁。<span lang="EN-US"><o:p></o:p></span></p>
<p class="MsoNormal" style="TEXT-INDENT: 21pt; LINE-HEIGHT: 25pt; mso-char-indent-count: 2.0; mso-line-height-rule: exactly">问题人用狂犬病疫苗批号：<span lang="EN-US"><o:p></o:p></span></p>
<p class="MsoNormal" style="LINE-HEIGHT: 25pt; mso-line-height-rule: exactly">江苏延申供公司的<span lang="EN-US">4</span>批产品（批号：<st1:chmetcnv w:st="on" unitname="F" sourcevalue="200810" hasspace="False" negative="False" numbertype="1" tcsc="0"><span lang="EN-US">200810F</span></st1:chmetcnv><span lang="EN-US">01.1</span>、<span lang="EN-US">20080834-6</span>、<span lang="EN-US">20080837-4</span>、<span lang="EN-US">20080939-3</span>）和河北福尔公司的<span lang="EN-US">3</span>批产品（批号：<span lang="EN-US">20080753 </span>、<span lang="EN-US">20080754-1</span>、<span lang="EN-US">20080758</span>）<span lang="EN-US"><o:p></o:p></span></p>
<p class="MsoNormal" style="TEXT-INDENT: 21pt; LINE-HEIGHT: 25pt; mso-char-indent-count: 2.0; mso-line-height-rule: exactly">报告四：<span style="mso-ascii-font-family: ˎ̥">从媒体报道来看，此次事件中的疫苗不属于安全性问题，只是没有</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">“</span><span style="mso-ascii-font-family: ˎ̥">药效</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">”</span><span style="mso-ascii-font-family: ˎ̥">，也尚未接到严重的不良反应报告。这应当是不幸中的万幸，但救命针</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">“</span><span style="mso-ascii-font-family: ˎ̥">不救命</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">”</span><span style="mso-ascii-font-family: ˎ̥">本身就是天大的罪过。</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥"> <o:p></o:p></span></p>
<p class="MsoNormal" style="MARGIN-BOTTOM: 9pt; LINE-HEIGHT: 25pt; TEXT-ALIGN: left; mso-pagination: widow-orphan; mso-line-height-rule: exactly" align="left"><span lang="EN-US" style="FONT-FAMILY: ˎ̥"> <span style="mso-spacerun: yes"> </span></span><span style="mso-ascii-font-family: ˎ̥">值得注意的是，</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">“</span><span style="mso-ascii-font-family: ˎ̥">问题疫苗</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">”</span><span style="mso-ascii-font-family: ˎ̥">是今年</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">3</span><span style="mso-ascii-font-family: ˎ̥">月至</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">7</span><span style="mso-ascii-font-family: ˎ̥">月注射的，距离现在</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">5</span><span style="mso-ascii-font-family: ˎ̥">到</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">9</span><span style="mso-ascii-font-family: ˎ̥">个月时间，而狗咬猫抓后的三个月至半年，正是狂犬病最易发作的时间。为此，疫苗生产企业首先必须站出来，为自己的过失公开道歉。对于政府有关部门来说，一方面要严肃查处事件起因，依法问责；另一方面要亡羊补牢，对接种对象展开跟踪回访，一旦有人因注射疫苗无效，而导致狂犬病发作，要为他做好索赔等维权事宜。</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥"> <o:p></o:p></span></p>
<p class="MsoNormal" style="MARGIN-BOTTOM: 9pt; LINE-HEIGHT: 25pt; TEXT-ALIGN: left; mso-pagination: widow-orphan; mso-line-height-rule: exactly" align="left"><span lang="EN-US" style="FONT-FAMILY: ˎ̥"> <span style="mso-spacerun: yes"> </span></span><span style="mso-ascii-font-family: ˎ̥">当然，眼下当务之急还是尽快为相关人群进行疫苗补种，将这一事件的影响降到最低。尽管疾控部门已经通过报纸、网站发布了信息，但肯定还有群众对此不知情。因此，免费补种不能</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">“</span><span style="mso-ascii-font-family: ˎ̥">坐等上门</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">”</span><span style="mso-ascii-font-family: ˎ̥">，而应</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">“</span><span style="mso-ascii-font-family: ˎ̥">主动出击</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">”</span><span style="mso-ascii-font-family: ˎ̥">，要全面查清每一支疫苗的流向，根据接种记录，逐一通知到每一位被接种对象。</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥"> <o:p></o:p></span></p>
<p class="MsoNormal" style="MARGIN-BOTTOM: 9pt; LINE-HEIGHT: 25pt; TEXT-ALIGN: left; mso-pagination: widow-orphan; mso-line-height-rule: exactly" align="left"><span lang="EN-US" style="FONT-FAMILY: ˎ̥"> <span style="mso-spacerun: yes"> </span></span><span style="mso-ascii-font-family: ˎ̥">从一针致命的</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">“</span><span style="mso-ascii-font-family: ˎ̥">双黄连注射液</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">”</span><span style="mso-ascii-font-family: ˎ̥">，到打了无效的</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">“</span><span style="mso-ascii-font-family: ˎ̥">问题狂犬疫苗</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">”</span><span style="mso-ascii-font-family: ˎ̥">，面对多发的药品安全事件，公众不禁发出</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">“</span><span style="mso-ascii-font-family: ˎ̥">我的安全谁做主</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥">”</span><span style="mso-ascii-font-family: ˎ̥">的追问。除就事论事的个案处理外，更需从制度层面筑牢篱笆：尽快建立公法意义上的药害赔偿救济机制，对药害责任人进行严厉追究，对药害受害者进行救济，为每一个生命撑起坚实可靠的保护伞</span><span lang="EN-US" style="FONT-FAMILY: ˎ̥"><o:p></o:p></span></p>
<p class="MsoNormal" style="TEXT-INDENT: 21pt; LINE-HEIGHT: 25pt; mso-char-indent-count: 2.0; mso-line-height-rule: exactly"><span style="BACKGROUND: yellow; mso-highlight: yellow">气愤之余，希望此次事件的披露能够真正引发大家对根本问题的思考，希望有管部门能将民众权益生命安全放在首要位置，更希望随着此次事件披露，能够给所有人一个警示，提高接种疫苗的安全意识，提高自身保护的意识，维权不是一个人的责任，而是所有人的责任。</span><span lang="EN-US"><o:p></o:p></span></p>
<p class="MsoNormal" style="TEXT-INDENT: 21pt; LINE-HEIGHT: 25pt; mso-char-indent-count: 2.0; mso-line-height-rule: exactly"><span style="BACKGROUND: yellow; mso-highlight: yellow">我们已经就此热点问题建设了专属讨论<span lang="EN-US">QQ</span>群，上述涉及二十七个省区市的已接种的朋友和有接种问题的朋友可随时加入我们，也希望更多的专业医疗工作者、律师、能够为这些维权的人贡献自己的一份热心善心与力量。</span><span lang="EN-US"><span style="mso-spacerun: yes"> </span>QQ</span>群：<span lang="EN-US">7 2 0 7 5 6 0 7<o:p></o:p></span></p>
<p class="MsoNormal" style="TEXT-INDENT: 21pt; LINE-HEIGHT: 25pt; mso-char-indent-count: 2.0; mso-line-height-rule: exactly"><span lang="EN-US"><o:p> </o:p></span></p> 我没打，还好 怎么不早查出来啊，流到各国了，真是让人担心 支持楼主，呼吁真正关注民生 太可怕了 支持楼主 <p>又是监管不力，老百姓苦啊！</p>
页:
[1]